Last updated: 20 August 2019 at 12:19am EST

Raju S.K. Chaganti Net Worth




The estimated Net Worth of Raju S.K. Chaganti is at least $1.78 Millón dollars as of 25 June 2015. Raju Chaganti owns over 5,296 units of Cancer Genetics stock worth over $774,281 and over the last 12 years Raju sold CGIX stock worth over $1,002,197.

Raju Chaganti CGIX stock SEC Form 4 insiders trading

Raju has made over 4 trades of the Cancer Genetics stock since 2015, according to the Form 4 filled with the SEC. Most recently Raju sold 5,296 units of CGIX stock worth $63,552 on 25 June 2015.

The largest trade Raju's ever made was selling 46,454 units of Cancer Genetics stock on 9 June 2015 worth over $558,842. On average, Raju trades about 7,576 units every 2 days since 2013. As of 25 June 2015 Raju still owns at least 171,681 units of Cancer Genetics stock.

You can see the complete history of Raju Chaganti stock trades at the bottom of the page.



What's Raju Chaganti's mailing address?

Raju's mailing address filed with the SEC is 201 ROUTE 17 NORTH, 2ND FLOOR, , RUTHERFORD, NJ, 07070.

Insiders trading at Cancer Genetics

Over the last 12 years, insiders at Cancer Genetics have traded over $1,720,897 worth of Cancer Genetics stock and bought 3,891,559 units worth $4,573,241 . The most active insiders traders include John Pappajohn, Tommy G Thompson y John A Roberts. On average, Cancer Genetics executives and independent directors trade stock every 35 days with the average trade being worth of $340,207. The most recent stock trade was executed by John A Roberts on 31 January 2019, trading 185,436 units of CGIX stock currently worth $42,650.



What does Cancer Genetics do?



Complete history of Raju Chaganti stock trades at Cancer Genetics

Persona
Trans.
Transacción
Precio total
Raju S.K. Chaganti
Director
Venta $63,552
25 Jun 2015
Raju S.K. Chaganti
Director
Venta $84,070
12 Jun 2015
Raju S.K. Chaganti
Director
Venta $558,842
9 Jun 2015
Raju S.K. Chaganti
Director
Venta $295,733
8 Jun 2015


Cancer Genetics executives and stock owners

Cancer Genetics executives and other stock owners filed with the SEC include: